Recent Finacing
Recent Raise
Procavea develops engineered protein-cage delivery platforms for RNA therapeutics (notably siRNA), designed to be manufacturable, biodegradable, non-toxic, cargo-flexible, and capable of cell-type-specific targeting.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor